Zurich Cantonal Bank
IMNM icon

Zurich Cantonal Bank’s Immunome IMNM Stock Holding History

Zurich Cantonal Bank’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22M Buy
57,673
+13,185
+30% +$282K ﹤0.01% 1432
2026
Q1 		$973K Buy
+44,488
New +$990K ﹤0.01% 1450
2025
Q4 		– Sell
-21,154
Closed -$371K – 3012
2025
Q3 		$248K Hold
21,154
– – ﹤0.01% 2095
2025
Q2 		$197K Buy
21,154
+13,143
+164% +$108K ﹤0.01% 2144
2025
Q1 		$53.9K Hold
8,011
– – ﹤0.01% 2507
2024
Q4 		$85.1K Hold
8,011
– – ﹤0.01% 2476
2024
Q3 		$117K Hold
8,011
– – ﹤0.01% 2368
2024
Q2 		$96.9K Buy
+8,011
New +$125K ﹤0.01% 2386

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Zurich Cantonal Bank's IMNM Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Immunome (IMNM) stake by 30% in Q2 2026, buying an estimated $282K and bringing the position to 57,673 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1432.

Zurich Cantonal Bank first reported a position in IMNM in Q2 2024 and has held it in 8 quarters since. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Zurich Cantonal Bank held 57,673 shares of Immunome worth $1.22M as of Q2 2026.
  • Zurich Cantonal Bank bought 13,185 Immunome shares in Q2 2026, an estimated $282K.
  • Immunome made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1432 holding.
  • Zurich Cantonal Bank first reported a position in Immunome in Q2 2024 and has held it in 8 quarters since.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.